MolecuLight Announces CMS has Assigned an APC Reimbursement Code for its MolecuLight i:X® Procedure for Bacterial Imaging using Fluorescence

June 11, 2020 -New Code Enables Facility Reimbursement to Hospital Outpatient Centers Performing MolecuLight’s Procedure Benefiting Wound Care Patients

Toronto, CANADA – (June 11, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces that the Centers for Medicare & Medicaid Services (CMS) has

Read More

MolecuLight Announces Industry Partnership and Virtual Exhibit of its MolecuLight i:X® Platform at WoundCon™ 2020, the Largest Conference for Wound Care

April 1, 2020 -Novel Virtual Conference Attracts 10,000 Wound Care Professionals as Alternate to Live Medical Conferences Given Travel Challenges Due to Covid-19

Toronto, CANADA and Atlantic Beach, USA – (April 1, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces its Sponsorship and participation

Read More

First Published Study to Report In Vitro Detection of Fluorescence from Bacteria in Biofilm with Point-of-care Wound Imaging Device

March 3, 2020 -In Vitro Study Demonstrates Detectable Red Fluorescence from 88% of Planktonic and Biofilm Wound Pathogens when Imaged by the MolecuLight i:X® Imaging Device

Toronto, CANADA – (March 3, 2020) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time detection of bacteria in wounds, announces the publication of  “… Read More

New MolecuLight i:X® Upgrade Enables Faster, More Accurate Digital Wound Measurement

February 20, 2020 -i:X Platform’s Precise Wound Measurement, along with Fluorescence Imaging, for More Accurate Detection and Ongoing Documentation of Wounds

Toronto, CANADA – (February 20, 2020) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time detection of bacteria in wounds, released a significant upgrade to its i:X digital wound measurement

Read More